Cargando…

Targeting C-type lectin receptors: a high-carbohydrate diet for dendritic cells to improve cancer vaccines

There is a growing understanding of why certain patients do or do not respond to checkpoint inhibition therapy. This opens new opportunities to reconsider and redevelop vaccine strategies to prime an anticancer immune response. Combination of such vaccines with checkpoint inhibitors will both provid...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Dinther, Dieke, Stolk, Dorian A., van de Ven, Rieneke, van Kooyk, Yvette, de Gruijl, Tanja D., den Haan, Joke M. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Society for Leukocyte Biology 2017
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5597514/ https://www.ncbi.nlm.nih.gov/pubmed/28729358 http://dx.doi.org/10.1189/jlb.5MR0217-059RR

Ejemplares similares

Lipo-Based Vaccines as an Approach to Target Dendritic Cells for Induction of T- and iNKT Cell Responses
por: Stolk, Dorian A., et al.
Publicado: (2020)

Comparison of Protein and Peptide Targeting for the Development of a CD169-Based Vaccination Strategy Against Melanoma
por: van Dinther, Dieke, et al.
Publicado: (2018)

Liposomal Nanovaccine Containing α-Galactosylceramide and Ganglioside GM3 Stimulates Robust CD8(+) T Cell Responses via CD169(+) Macrophages and cDC1
por: Grabowska, Joanna, et al.
Publicado: (2021)

Positive & Negative Roles of Innate Effector Cells in Controlling Cancer Progression
por: Stolk, Dorian, et al.
Publicado: (2018)

Dendritic Cell Plasticity in Tumor-Conditioned Skin: CD14(+) Cells at the Cross-Roads of Immune Activation and Suppression
por: van de Ven, Rieneke, et al.
Publicado: (2013)

Activation of CD8(+) T Cell Responses after Melanoma Antigen Targeting to CD169(+) Antigen Presenting Cells in Mice and Humans
por: van Dinther, Dieke, et al.
Publicado: (2019)

Comparative phenotypic and functional analysis of migratory dendritic cell subsets from human oral mucosa and skin
por: Kosten, Ilona Jennifer, et al.
Publicado: (2017)

Palmitoylated antigens for the induction of anti-tumor CD8(+) T cells and enhanced tumor recognition
por: Stolk, Dorian A., et al.
Publicado: (2021)

Glycan-Modified Apoptotic Melanoma-Derived Extracellular Vesicles as Antigen Source for Anti-Tumor Vaccination
por: Horrevorts, Sophie K., et al.
Publicado: (2019)

Immunotherapy Goes Local: The Central Role of Lymph Nodes in Driving Tumor Infiltration and Efficacy
por: van Pul, Kim M., et al.
Publicado: (2021)

Tumor-mediated inhibition of human dendritic cell differentiation and function is consistently counteracted by combined p38 MAPK and STAT3 inhibition
por: Oosterhoff, Dinja, et al.
Publicado: (2012)

Activation of the C-Type Lectin MGL by Terminal GalNAc Ligands Reduces the Glycolytic Activity of Human Dendritic Cells
por: Zaal, Anouk, et al.
Publicado: (2020)

Bacterial inclusion bodies function as vehicles for dendritic cell-mediated T cell responses
por: Schetters, Sjoerd T. T., et al.
Publicado: (2019)

C-type Lectin Receptors for Tumor Eradication: Future Directions
por: Streng-Ouwehand, Ingeborg, et al.
Publicado: (2011)

Ligand Binding and Signaling of Dendritic Cell Immunoreceptor (DCIR) Is Modulated by the Glycosylation of the Carbohydrate Recognition Domain
por: Bloem, Karien, et al.
Publicado: (2013)

Selectively hampered activation of lymph node-resident dendritic cells precedes profound T cell suppression and metastatic spread in the breast cancer sentinel lymph node
por: van Pul, Kim M., et al.
Publicado: (2019)

Counteracting breast-cancer induced immune suppression by reactivating lymph node-resident conventional dendritic cells (LNR-cDC)
por: van de Ven, Rieneke, et al.
Publicado: (2015)

Oncolytic adenovirus ORCA‐010 increases the type 1 T cell stimulatory capacity of melanoma‐conditioned dendritic cells
por: López González, M., et al.
Publicado: (2020)

Whole-cell cancer vaccination: from autologous to allogeneic tumor- and dendritic cell-based vaccines
por: de Gruijl, Tanja D., et al.
Publicado: (2008)

Functional characterization of a STAT3-dependent dendritic cell-derived CD14(+) cell population arising upon IL-10-driven maturation
por: Lindenberg, Jelle J., et al.
Publicado: (2013)

Therapeutic Liposomal Vaccines for Dendritic Cell Activation or Tolerance
por: Nagy, Noémi Anna, et al.
Publicado: (2021)

Immunological dynamics after subcutaneous immunization with a squalene‐based oil‐in‐water adjuvant
por: Schetters, Sjoerd T. T., et al.
Publicado: (2020)

Glyco-Dendrimers as Intradermal Anti-Tumor Vaccine Targeting Multiple Skin DC Subsets
por: Duinkerken, Sanne, et al.
Publicado: (2019)

Breast cancer-induced immune suppression in the sentinel lymph node is effectively countered by CpG-B in conjunction with inhibition of the JAK2/STAT3 pathway
por: van Pul, Kim M, et al.
Publicado: (2020)

Incorporation of Toll-Like Receptor Ligands and Inflammasome Stimuli in GM3 Liposomes to Induce Dendritic Cell Maturation and T Cell Responses
por: Nijen Twilhaar, Maarten K., et al.
Publicado: (2022)

Monocyte-derived APCs are central to the response of PD1 checkpoint blockade and provide a therapeutic target for combination therapy
por: Schetters, Sjoerd T T, et al.
Publicado: (2020)

IL-10 Conditioning of Human Skin Affects the Distribution of Migratory Dendritic Cell Subsets and Functional T Cell Differentiation
por: Lindenberg, Jelle J., et al.
Publicado: (2013)

Systematic Dual Targeting of Dendritic Cell C-Type Lectin Receptor DC-SIGN and TLR7 Using a Trifunctional Mannosylated Antigen
por: Li, Rui-Jun Eveline, et al.
Publicado: (2019)

The Consequences of Multiple Simultaneous C-Type Lectin–Ligand Interactions: DCIR Alters the Endo-Lysosomal Routing of DC-SIGN
por: García-Vallejo, Juan J., et al.
Publicado: (2015)

Pre-operative intradermal administration of CpG-B ± GM-CSF in stage I-III melanoma patients arms the sentinel lymph node: evidence for reduced tumor spread
por: van den Hout, Mari F, et al.
Publicado: (2013)

Selective tumor antigen vaccine delivery to human CD169(+) antigen-presenting cells using ganglioside-liposomes
por: Affandi, Alsya J., et al.
Publicado: (2020)

CD169 Defines Activated CD14(+) Monocytes With Enhanced CD8(+) T Cell Activation Capacity
por: Affandi, Alsya J., et al.
Publicado: (2021)

Interaction of Polysialic Acid with CCL21 Regulates the Migratory Capacity of Human Dendritic Cells
por: Bax, Marieke, et al.
Publicado: (2009)

Human Milk Oligosaccharide 2′-Fucosyllactose Inhibits Ligand Binding to C-Type Lectin DC-SIGN but Not to Langerin
por: Mukherjee, Reshmi, et al.
Publicado: (2022)

Profiling of suppressive immune subsets in metastasis negative and positive sentinel lymph nodes from patients with HER2- breast cancer
por: van de Ven, Rieneke, et al.
Publicado: (2014)

Neutrophils mediate immune modulation of dendritic cells through glycosylation-dependent interactions between Mac-1 and DC-SIGN
por: van Gisbergen, Klaas P.J.M., et al.
Publicado: (2005)

High susceptibility of c-KIT(+)CD34(+) precursors to prolonged doxorubicin exposure interferes with Langerhans cell differentiation in a human cell line model
por: van de Ven, Rieneke, et al.
Publicado: (2011)

Antigen targeting reveals splenic CD169(+) macrophages as promoters of germinal center B‐cell responses
por: Veninga, Henrike, et al.
Publicado: (2015)

Mouse DC-SIGN/CD209a as Target for Antigen Delivery and Adaptive Immunity
por: Schetters, Sjoerd T. T., et al.
Publicado: (2018)

Macrophage galactose-type lectin (MGL) is induced on M2 microglia and participates in the resolution phase of autoimmune neuroinflammation
por: Ilarregui, Juan M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vr7og3jj8re43q9pj9ggpjtf6s